New Content
edit
Get The App!
Login
Register
Go
Go
Hematology-Oncology
On The Go
MinuteCE
Quiz Challenge
IMPACT Live
Slides and Resources
Featured Programs
Contemporary Challenges and New Approaches in Metastatic Melanoma
9 episodes - 1.75 credit hours
Various
Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC
6 episodes - 1.25 credit hours
Various
Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS
8 episodes - 1.25 credit hours
Various
Advances in Genitourinary Cancers: Integrating Data into Clinical Practice and COVID-19 Consideration
5 episodes - 1.00 credit hours
Various
Featured Videos
Loading the player...
SHARE THIS VIDEO
MORE VIDEOS
Molecular Profiling in AML
04:52
Phase IB/II Study of Nivolumab with Azacytidine in Patients with Relapsed AML
1
2
3
4
5
6
7
8
9
10
11
Featured On The Go Programs
view all
Best Practices During COVID-19
Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC
6 episodes - 1.25 credit hours
Various
Contemporary Challenges and New Approaches in Metastatic Melanoma
9 episodes - 1.75 credit hours
Various
Nursing On The Go: Creating Innovative Care and Approaches in the COVID-19 Era
3 episodes - non-certified
Various
"Best Practice" Information During the Rapidly Evolving Era of COVID-19
9 episodes - 2.00 credit hours
Multiple Speakers
Immuno-Oncology
Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC
6 episodes - 1.25 credit hours
Various
Contemporary Challenges and New Approaches in Metastatic Melanoma
9 episodes - 1.75 credit hours
Various
IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical Practice
4 episodes - 2.00 credit hours
Various
TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal Cell Carcinoma (mccRCC)
13 episodes - 2.00 credit hours
Various
Frontline Systemic Therapy for Metastatic Melanoma
7 episodes - 1.00 credit hour
Various
Highlights from the 2020 SOHO Meeting
10 episodes - non-certified
Various Speakers
Navigating First-Line Checkpoint Inhibitor Combinations in Non-Small Cell Lung Cancer (NSCLC) in the Era of COVID-19
12 episodes - 2.00 credit hours
Various
Advances in First-Line NSCLC: Integrating the Latest Congress Data into Clinical Practice
3 episodes - 0.50 credit hours
Various
Defining the Role of Immune Checkpoint Inhibitor Therapy in Advanced Hepatocellular Carcinoma (HCC)
9 episodes - 1.50 credit hours
Various
Innovative Solutions to Managing Treatment Related Adverse Events
7 episodes - 1.50 credit hours
- Expired
Various
Recognizing and Managing Immunotherapy Related Adverse Events
8 episodes - 1.25 credit hours
- Expired
Various
Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies
10 episodes - 1.50 credit hours
- Expired
Various
Highlights from Oncology Nursing Society (ONS) 2019 – “Growing Together, Transforming Care”
12 episodes - non-certified
Various Speakers
Highlights from Oncology Nursing Society (ONS) 2018 – “One Nurse. One Moment. One Action”
10 episodes - non-certified
Various Speakers
Highlights from Oncology Nursing Society (ONS) 2017 – “Elevate Your Passion”
16 episodes - non-certified
Various Speakers
Optimizing the Treatment Continuum in Metastatic Colorectal Cancer (mCRC)
11 episodes - non-certified
John L. Marshall, MD
Bone Marrow/Stem Cell Transplantation
Highlights from the 2020 SOHO Meeting
10 episodes - non-certified
Various Speakers
SOHO 2019 Annual Meeting - Cellular Therapy
1 episodes - non-certified
Various
Innovative Solutions to Managing Treatment Related Adverse Events
7 episodes - 1.50 credit hours
- Expired
Various
Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies
10 episodes - 1.50 credit hours
- Expired
Various
The Role of JAK Inhibition in Graft-Versus-Host Disease (GVHD)
5 episodes - 1.00 credit hour
- Expired
Mark A. Schroeder, MD
Recent Advances in the Treatment of Adult and Pediatric Patients with Hepatic Veno-Occlusive Disease (VOD)
9 episodes - 1.25 credit hours
- Expired
Various Speakers
The Multidisciplinary Approach to Screening and Treating Adult and Pediatric Patients with Hepatic Veno-Occlusive Disease (VOD)
8 episodes - 1.25 credit hours
Various Speakers
Gastrointestinal Cancers (GI)
IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical Practice
4 episodes - 2.00 credit hours
Various
Highlights from the 2020 Gastrointestinal Cancers Symposium - Immunotherapy in GI Malignancies
10 episodes - 1.50 credit hours
Various
Defining the Role of Immune Checkpoint Inhibitor Therapy in Advanced Hepatocellular Carcinoma (HCC)
9 episodes - 1.50 credit hours
Various
Innovative Solutions to Managing Treatment Related Adverse Events
7 episodes - 1.50 credit hours
- Expired
Various
Recognizing and Managing Immunotherapy Related Adverse Events
8 episodes - 1.25 credit hours
- Expired
Various
Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies
10 episodes - 1.50 credit hours
- Expired
Various
GI Weekly: Outcomes 365
20 episodes - non-certified
Various Speakers
Oncology Nursing Weekly
1 episodes - non-certified
Various Speakers
GI Weekly Special Edition: 2019 Gastrointestinal Cancers Symposium
8 episodes - non-certified
Various Speakers
IMPACT Live GI Oncology Flip Classroom Training
4 episodes - non-certified
Johanna Bendell, MD
GI Weekly Special Edition: ASCO 2018
5 episodes - non-certified
Various Speakers
Highlights in Gastrointestinal Cancers (GI) from ASCO 2017
7 episodes - non-certified
Various Speakers
Highlights in Gastrointestinal Cancers (GI) from ASCO 2016
12 episodes - non-certified
John Marshall, MD et al.
Optimizing the Treatment Continuum in Metastatic Colorectal Cancer (mCRC)
11 episodes - non-certified
John L. Marshall, MD
Genetics and Genomics
Highlights from the 2020 SOHO Meeting
10 episodes - non-certified
Various Speakers
ISTH 2020 Roundtable Discussions - Anticoagulation and Hemophilia
8 episodes - non-certified
Various Speakers
Highlights From ISTH 2020
22 episodes - non-certified
Various Speakers
Recognizing and Managing Immunotherapy Related Adverse Events
8 episodes - 1.25 credit hours
- Expired
Various
Genitourinary Cancers (GU)
Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC
6 episodes - 1.25 credit hours
Various
Advances in Genitourinary Cancers: Integrating Data into Clinical Practice and COVID-19 Consideration
5 episodes - 1.00 credit hour
Various
TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal Cell Carcinoma (mccRCC)
13 episodes - 2.00 credit hours
Various
Highlights from the 2020 Genitourinary Cancers Symposium - Immunotherapy in GU Malignancies
6 episodes - 1.00 credit hour
Various
Innovative Solutions to Managing Treatment Related Adverse Events
7 episodes - 1.50 credit hours
- Expired
Various
Recognizing and Managing Immunotherapy Related Adverse Events
8 episodes - 1.25 credit hours
- Expired
Various
Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies
10 episodes - 1.50 credit hours
- Expired
Various
Impacting Prostate Cancer Through New Approaches and Therapies
11 episodes - 1.50 credit hours
Daniel P. Petrylak, MD; Neal D. Shore, MD, FACS
Highlights from ASCO 2017
4 episodes - non-certified
Various
Highlights in Genitourinary Cancers (GU) from ASCO 2016
8 episodes - non-certified
Nick Vogelzang, MD et al.